Citation to this article as recorded by
Ribavirin for treating Crimean Congo haemorrhagic
fever Cochrane Database of Systematic Reviews |
Current Therapies for Biosafety Level 4 Pathogens Methods and Principles in Medicinal Chemistry |
Pre-Exposure and Post-Exposure Prophylaxis of Crimean-Congo
Hemorrhagic Fever Biotechnology and Health Sciences Vol. 1, Issue 2, , 2014 |
Risk Factors Associated With Poor Prognosis in Children With
Crimean-Congo Hemorrhagic Fever International Journal of Infection Vol. 1, Issue 3, , 2014 |
Data collection for risk assessments on animal health (Acronym:
DACRAH) : Final Report EFSA Supporting Publications Vol. 14, Issue 1, 1171E, 2017 |
Tick Borne Crimean-Congo Haemorrhagic Fever in Fars Province, Southern Iran: Epidemiologic Characteristics and Vector Surveillance Pakistan Journal of Biological Sciences Vol. 9, Issue 14, 2681, 2006 |
Report of a Family with Crimean-Congo Hemorrhagic Fever Following
Contact with Frozen Meat: A Case Seires Study Archives of Clinical Infectious Diseases Vol. In Press, Issue In Press, , 2017 |
A Systematic Review of Treatment Strategies Including Future Novel Therapies in Crimean-Congo Hemorrhagic Fever International Journal of Infection Vol. 8, Issue 2, , 2021 |
How to cite this article
Batool Sharifi-Mood, Roya Alavi-Naini, Maliheh Metanat and Fatemeh Rakhshani, 2006. Ribavirin: An Effective Drug for Treatment of Children with Crimean-Congo Hemorrhagic Fever: A Seven-years Experience. Pakistan Journal of Biological Sciences, 9: 1598-1600.
DOI: 10.3923/pjbs.2006.1598.1600
URL: https://scialert.net/abstract/?doi=pjbs.2006.1598.1600
DOI: 10.3923/pjbs.2006.1598.1600
URL: https://scialert.net/abstract/?doi=pjbs.2006.1598.1600